This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCIs new live video webinar: PBM Industry Update: Trends, Challenges, and What's Ahead This event will be broadcast live on Friday, April 4, 2025, from 12:00 p.m. This event is part of The Drug Channels 2025 Video Webinar Series.
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for his latest video webinar: Drug Channels Update: Buy-and-Bill Market Trends. This event is part of The Drug Channels 2021 Quarterly Video Webinar Series. The webinar will be 90 minutes to accommodate audience questions.
Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCIs new live video webinar: Whats Next for Retail Pharmacy: Data, Debate, and Disruption This event will be broadcast live on: Friday, June 20, 2025 12:00 p.m. It is part of The Drug Channels 2025 Video Webinar Series.
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: Drug Channels Outlook 2024 This event will be broadcast live on Friday, December 15, 2023 12:00 p.m. The webinar will be broadcast from the Drug Channels studio in beautiful downtown Philadelphia. (Or,
Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s latest live video webinar: Drug Channel Implications of the Inflation Reduction Act This event will be broadcast live on Friday, April 5, 2024, from 12:00 p.m. This event is part of The Drug Channels 2024 Video Webinar Series.
Fein, CEO of Drug Channels Institute (DCI), for three live video webinars during 2022. Click here to order the Drug Channels 2022 Video Webinar Series. He’ll share DCI’s latest market data to help you stay on top of new developments. During these events, Dr. Fein will address the latest issues confronting the U.S. drug channel.
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. This event is part of The Drug Channels 2022 Video Webinar Series. This event will be broadcast live on July 29, 2022 , from 12:00 p.m. to 1:30 p.m.
I invite you to join me for three new video webinars during 2023. I’ll share DCI’s latest market data to help you stay on top of new developments. Click here to order the Drug Channels 2023 Video Webinar Series. During these events, I'll address the latest issues confronting the U.S. drug channel. to 1:30 p.m.
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: PBM Industry Update: Trends, Controversies, and Outlook. This event is part of The Drug Channels 2022 Video Webinar Series. Broadcast live on April 22, 2022 , from 12:00 p.m. to 1:30 p.m. WHAT YOU WILL LEARN.
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook This event will be broadcast live on Friday, March 31, 2023, from 12:00 p.m. to 1:30 p.m.
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding This event will be broadcast live on Friday, June 23, 2023, from 12:00 p.m. We use Zoom technology for this webinar.
Below, we break down the latest market share data from Drug Channels Institute (DCI), explore the developments driving these changes, and examine what they signal for the future of the PBM landscape.
This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: Drug Channels Outlook 2023. Below, I highlight three unexpected findings from the data regarding GoodRx’s market position, when people use discount cards, how much they save, and why PBMs should still be worried about this market.
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new live video webinar: Drug Channels Outlook 2022. This event is part of The Drug Channels 2021 Quarterly Video Webinar Series. The Outlook 2022 marks our third annual outlook webinar. Broadcast live on December 17, 2021.
In 2022, the PBM market remained highly consolidated—although there were some intriguing share shifts among the largest players. Below, you’ll find Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share based on equivalent prescription claims. to 1:30 p.m.
Accelerate customer speed to market With a modern and integrated user experience, AI solutions put the right data and insights into the right hands in real time. As a result, drug developers make better decisions more quickly (removing 50% of study timeline whitespace) to bring new therapies to market faster. Get in touch.
For more on 340B and the specialty market, join me for my upcoming July 29 live video webinar, Specialty Drugs Update: Trends, Controversies, and Outlook. Manufacturers’ contract pharmacy restrictions have slowed the out-of-control program growth—with some unanticipated benefits for the biggest players.
prescription dispensing revenues reached $621 billion in 2023, driven by accelerating GLP-1 prescriptions and an expanding post-pandemic market. Find out at my upcoming live video webinar, Drug Channel Implications of the Inflation Reduction Act , on April 5, 2024, from 12:00 p.m. drug pricing, reimbursement, and dispensing system.
This week, Im rerunning some popular posts while I prepare for Fridays Drug Channels Outlook 2025 live video webinar. During Friday's webinar, Ill share some updated thoughts on biosimilars and PBMs private label products. The Humira biosimilar market just took another step forwardbut remains far from its ideal state.
Drug Channel Institute is pleased to announce The Drug Channels 2025 Video Webinar Series. Fein for three live video webinars during 2025. He’ll share DCI’s latest market data to help you stay on top of new developments. Join Dr. Adam J. During these events, Dr. Fein will address the latest issues confronting the U.S.
Drug Channels Institute’s latest exclusive analysis of the 2025 market reveals a highly concentrated market structure increasingly dominated by a handful of major players: About 32,000 pharmacy locations—nearly 60% of the entire U.S. It was meant to be part of patient care.” Fein, Ph.D., All rights reserved.
The webinar largely consisted of summarizing the general requirements under Parts 803, 806 and 820.198, which we do not reproduce here ( but see another of our prior blog posts discussing these requirements and their applicable to LDTs in greater detail; you can also find FDA’s slides from the webinar here ). By Steven J.
Find out at my upcoming live video webinar, Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook , on March 31, 2023, from 12:00 p.m. We’re offering special discounted pricing if you order before April 3, 2023. How will GoodRx and Mark Cuban Cost Plus Drug Company affect the pharmacy industry? to 1:30 p.m.
Today’s guest post comes from Chris Dowd, Senior VP of Market Development at ConnectiveRx. To learn more, register for ConnectiveRx’s free webinar on December 11: The Perfect Storm? He then outlines three actions that should guide manufacturers' preparation. Patient Support Programming in 2025 and Beyond. All rights reserved.
Join us for an exclusive webinar where well guide you through the essential steps of meeting Japans regulations and strict quality requirement. Join us for an exclusive webinar where well guide you through the essential steps of meeting Japans regulations and strict quality requirement. Register now to secure your spot.
Drug Channel Institute is pleased to announce The Drug Channels 2024 Video Webinar Series. Fein for three live video webinars during 2024. He’ll share DCI’s latest market data to help you stay on top of new developments. Join Dr. Adam J. During these events, Dr. Fein will address the latest issues confronting the U.S.
Pharma Marketing Trends: Key Takeaways from Digital Pharma East 2024 swheeler Mon, 08/26/2024 - 14:05 Thu, 09/26/2024 - 13:00 Resource Type Webinar Stephanie Butler Promotion Start Tue, 08/27/2024 - 14:15 Promotion End Thu, 02/27/2025 - 14:15 Duration 60 minutes Did you miss the buzz at Digital Pharma East 2024? Click here to login.
This week, I’m rerunning some popular posts while I prepare for today's live video webinar: Drug Channels Update: Buy-and-Bill Market Trends. Click here to see the original post and comments from June 2021. The Bureau of Labor Statistics (BLS) has recently released its employment and salary data for 2020.
A Pharma Marketers' Roadmap to Data Privacy Compliance : Are You Ready for 2025? swheeler Tue, 10/15/2024 - 19:53 Thu, 11/21/2024 - 13:00 Resource Type Webinar Ben Chapman Duration 60 minutes Join for an insightful webinar on the evolving privacy landscape impacting pharma marketers in 2025. Click here to login.
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for his latest live video webinar: Drug Channels Update: 340B Controversies and Outlook. This event is part of The Drug Channels 2021 Quarterly Video Webinar Series. The webinar will be 90 minutes to accommodate audience questions.
In my most recent video webinar , I explored how plans and PBMs are turning to novel—and highly controversial—benefit design tools that access manufacturers’ patient support spending: copay accumulators, maximizers, and alternative funding programs.
Learn about Adobe’s commitment to maintaining HIPAA-ready standards within commerce solutions and join Perficient and Adobe for a webinar hosted by CMSWire. EST Secure Digital Conversion: Unveiling Adobe’s HIPAA-Ready Commerce Solution webinar hosted by CMSWire. Register Today! Thursday, February 22 at 12:00 P.M.
You’ll hear exclusive insights from market leaders in omni-channel marketing on key strategies for improving outreach and engagement with AI-enabled, highly specific content selection and delivery.
Preparing Market Access & Others for Policy Change swheeler Wed, 09/06/2023 - 15:01 Tue, 10/24/2023 - 11:00 Resource Type Webinar Krista Gerhard Norman Koshkarian Duration 60 minutes In the US, several key trends and policy changes will impact manufacturers, payers, providers, patients, and other stakeholders.
The Unfiltered Truth about AI & Pharma Marketing dwunderlin Wed, 08/07/2024 - 12:04 Wed, 09/04/2024 - 14:00 Resource Type Webinar Chris Cullmann Doug Barr Promotion Start Thu, 08/08/2024 - 15:00 Promotion End Sat, 02/08/2025 - 15:00 Duration 60 Minutes You need to know where artificial intelligence disrupts the pharmaceutical marketing norms.
I then document how five multi-billion-dollar, for-profit, publicly traded pharmacy chains and pharmacy benefit managers (PBMs)—Cigna (via Express Scripts), CVS Health, UnitedHealth Group (via OptumRx), and Walgreens, Walmart—continue to dominate the 340B contract pharmacy market. Click here if you can’t see the video below.
Accelerating Time-to-Market: Balancing Speed, Compliance, and Operational Excellence jpiatt Mon, 04/28/2025 - 14:42 Tue, 06/24/2025 - 10:00 Resource Type Webinar Promotion Start Thu, 05/01/2025 - 08:30 Promotion End Sat, 11/01/2025 - 08:30 In the highly competitive world of drug development, few things matter more than getting to market first.
The integration of AI-powered market intelligence offers pharmaceutical companies a competitive edge by enabling real-time insights, predictive analytics, and strategic decision-making. Featuring an in-depth interview, well discuss how AI is shaping the future to increase cost efficiency, organisational agility and commercial success.
This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding. Click here to see the original post from April 2023. Our latest data appear below.
Innovation around digital health requires life science companies to respond to market needs faster without compromising on quality or cost. In this Pharma IQ webinar, Dassault Systèmes will analyze how to overcome the complex demands of digital manufacturing to improve production processes, control cost and assure quality.
Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook This event will be broadcast live on Friday, June 21, 2024, from 12:00 p.m. to 1:30 p.m.
In this on-demand webinar, Ingrid Holmes , Vice President of Global Clinical Operations at Altasciences, and Dr. Gary G. Various psychomotor and neuropsychological tests, including the measurement of reaction time, divided attention, selective attention, and memory, may still be appropriate.
Trust Transformed: Pharma Marketing in the Post-Cookie Era dwunderlin Tue, 05/07/2024 - 13:29 Tue, 06/11/2024 - 14:00 Resource Type Webinar David Minkin Clifton Covey Sonia V Gupta Duration 60 Minutes In the backdrop of digital advertising for pharmaceuticals we are undergoing a radical transformation as privacy becomes a paramount concern.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content